Confocal microlaparoscope for imaging the fallopian tube

Tzu-Yu Wu1, Andrew R Rouse2, Setsuko K Chambers3

  • 1University of Arizona, College of Optical Sciences, 1630 East University Boulevard, Tucson, Arizona 85721, United StatesbUniversity of Arizona, Department of Medical Imaging, PO Box 245067, Tucson, Arizona 85724, United States.

Insights

A new articulating confocal microlaparoscope allows in vivo imaging of the fallopian tube, aiding early detection of ovarian cancer. This technology addresses challenges in studying and diagnosing this deadly disease in its earliest, most treatable stages.

Area of Science:

  • Gynecologic Oncology
  • Medical Imaging
  • Surgical Technology

Background:

  • Ovarian cancer can originate in the fallopian tube, but limited access hinders study and early diagnosis.
  • Existing imaging technologies face challenges in visualizing the fallopian tube's internal surfaces.
  • Early-stage diagnosis is crucial for effective ovarian cancer therapy.

Purpose of the Study:

  • To develop and evaluate a novel confocal microlaparoscope with an articulating tip for in vivo imaging of human fallopian tubes.
  • To enable visualization of the fallopian tube's epithelial surface for early ovarian cancer detection.

Main Methods:

  • Development of a 2.2-mm-diameter articulating distal tip for a confocal microlaparoscope.
  • Integration of a bare fiber bundle and automated dye delivery system for fluorescence imaging.
  • Compatibility with standard 5-mm surgical trocars for clinical application.

Main Results:

  • Successful ex vivo imaging of animal and human fallopian tube tissues.
  • Demonstration of in vivo imaging capabilities within the fallopian tube.
  • Presentation of fluorescence confocal imaging results using the articulating device.

Conclusions:

  • The articulating confocal microlaparoscope provides in vivo access to the human fallopian tube.
  • This technology has the potential to significantly improve early detection of ovarian cancer.
  • Further research and clinical application are warranted to assess its full impact on patient outcomes.